live Bab el-Mandeb shipping slumps after Houthi attacks on Saudi oil sites
Ship traffic through the Bab el-Mandeb Strait fell to its lowest level in months on Sunday after Yemen's Houthi movement attacked Saudi oil facilities...
AstraZeneca is acquiring Belgium-based EsoBiotec for $1 billion to expand its cell therapy capabilities, with the deal set to close in the second quarter.
AstraZeneca, the British-Swedish pharmaceutical and biotechnology joint venture, announced on Monday that it has reached an agreement to acquire EsoBiotec, according to a company press release.
The Belgium-based biotech firm has accepted AstraZeneca's $1 billion acquisition offer for its entire shareholding, with an initial payment of $425 million.
The deal is expected to be finalised in the second quarter of this year, subject to regulatory approvals and customary closing conditions.
"EsoBiotec will enhance and build upon the impact of our recent investments, representing a significant step towards realising our ambition to fully harness the potential of cell therapy," said Susan Galbraith, AstraZeneca's Executive Vice President.
Jean-Pierre Latere, CEO of EsoBiotec, stated: "We are excited to collaborate with AstraZeneca, a global leader in drug development, to advance our shared goal of delivering cost-effective, transformative cell therapies to a wider patient population. By combining our expertise and resources, we can accelerate the development of our in vivo platform, which utilises an innovative delivery technology with broad therapeutic potential."
EsoBiotec is a pioneering biotechnology company specialising in in vivo cell therapies for cancer, with early clinical studies showing promising results.
The company's Engineered NanoBody Lentiviral platform enhances the immune system's ability to combat cancer and has the potential to make cell therapy more accessible, reducing treatment times from weeks to just minutes.
Russian authorities said 11 people, including four children, had been killed by Ukraine in an overnight attack on a holiday camp, accusing Kyiv on Saturday of deliberately targeting civilians.
Iran will halt its own attacks as long as the United States maintains its pause on strikes, but Tehran remains sceptical of U.S. intentions, a senior Iranian source told on Sunday.
Kazakhstan's President Kassym-Jomart Tokayev called on Saturday for Russia and Ukraine to freeze the conflict and return to peace talks, saying a negotiated settlement remained possible despite the entrenched positions of both sides.
Marvel Studios used its return to San Diego Comic-Con to reveal several major projects, including a new Ghost Rider film starring Ryan Gosling and the long-awaited Black Panther 3.
U.S. President Donald Trump says Israeli Prime Minister Benjamin Netanyahu will visit Washington next week as tensions continue to rise across the Middle East.
A global shift towards healthier diets, more efficient farming and reduced food waste could cut greenhouse gas emissions from agriculture-related land-use change by 85% by 2050, according to a study published last week in the journal Nature.
Venezuelan health authorities have confirmed that three people have died from hantavirus infections, while stressing there is no evidence that the disease is spreading between people in the country.
Up to five cups of caffeinated coffee a day appears to be safe for most adults and may even help protect against heart disease and stroke, according to new research. Experts say energy drinks are a different story and may increase heart risks.
Portugal has become the first European Union member state to join HealthAI's Global Regulatory Network (GRN), as Europe prepares to implement new rules governing artificial intelligence across the bloc.
Nearly 7,000 people across the United States may have been infected with cyclosporiasis, a foodborne parasitic illness that causes prolonged diarrhoea. The outbreak has spread to 34 states, with health officials still trying to identify its source.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment